XML 32 R5.htm IDEA: XBRL DOCUMENT v3.20.4
Consolidated Statements of Stockholders' Equity - USD ($)
shares in Thousands, $ in Thousands
Cumulative Effect, Period of Adoption, Adjustment [Member]
Common Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Preferred Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Treasury Stock [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Additional Paid-in Capital [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Retained Earnings [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
AOCI Attributable to Parent [Member]
Cumulative Effect, Period of Adoption, Adjustment [Member]
Public Offering [Member]
Common Stock [Member]
Public Offering [Member]
Preferred Stock [Member]
Public Offering [Member]
Treasury Stock [Member]
Public Offering [Member]
Additional Paid-in Capital [Member]
Public Offering [Member]
Retained Earnings [Member]
Public Offering [Member]
AOCI Attributable to Parent [Member]
Public Offering [Member]
Common Stock [Member]
Preferred Stock [Member]
Treasury Stock [Member]
Additional Paid-in Capital [Member]
Retained Earnings [Member]
AOCI Attributable to Parent [Member]
Total
Balance (in shares) at Dec. 31, 2018                             16,642 0 0        
Balance at Dec. 31, 2018 $ 0 $ 0 $ 0 $ (7) $ 7 $ 0 $ 0               $ 17 $ 0 $ 0 $ 676,572 $ (509,406) $ 1,338 $ 168,521
Stock-based compensation                             $ 0 $ 0 $ 0 11,508 0 0 11,508
Issuance of stock (in shares)                             3,571 0 0        
Issuance of stock                             $ 4 $ 0 $ 0 25,773 0 0 25,777
Issuance of common stock consideration of MST (in shares)                             370 0 0        
Issuance of common stock consideration of MST                             $ 0 $ 0 $ 0 6,599 0 0 6,599
Exercise of stock options and warrants (in shares)                             38 0 0        
Exercise of stock options and warrants                             $ 0 $ 0 $ 0 538 0 0 538
Award of restricted stock units (in shares)                             70 0 0        
Award of restricted stock units                             $ 0 $ 0 $ 0 0 0 0 0
Return of common stock to pay withholding taxes on restricted stock (in shares)                             0 0 15        
Return of common stock to pay withholding taxes on restricted stock                             $ 0 $ 0 $ 0 (499) 0 0 (499)
Cancellation of treasury stock (in shares)                             0 0 (15)        
Cancellation of treasury stock                             $ 0 $ 0 $ 0 0 0 0 0
Other comprehensive income (loss)                             0 0 0 0 0 (2,708) (2,708)
Net loss                             $ 0 $ 0 $ 0 0 (154,201) 0 (154,201)
Balance (in shares) at Dec. 31, 2019                             20,691 0 0        
Balance at Dec. 31, 2019                             $ 21 $ 0 $ 0 720,484 (663,600) (1,370) 55,535
Stock-based compensation                             7,911 7,911
Issuance of stock (in shares)               14,122 7,937 0         66,241 0 0        
Issuance of stock               $ 14 $ 79 $ 0 $ 13,384 $ 0 $ 0 $ 13,477 $ 66 $ 0 $ 0 33,780 0 0 33,846
Exercise of stock options and warrants (in shares)                             4,913 0 0        
Exercise of stock options and warrants                             $ 5 $ 0 $ 0 3,335 0 0 3,340
Award of restricted stock units (in shares)                             286 0 0        
Award of restricted stock units                             $ 0 $ 0 $ 0 0 0 0 0
Return of common stock to pay withholding taxes on restricted stock (in shares)                             0 0 28        
Return of common stock to pay withholding taxes on restricted stock                             $ 0 $ 0 $ 0 (36) 0 0 (36)
Cancellation of treasury stock (in shares)                             0 0 (28)        
Cancellation of treasury stock                             $ 0 $ 0 $ 0 0 0 0 0
Other comprehensive income (loss)                             0 0 0 0 0 4,338 4,338
Net loss                             $ 0 $ 0 $ 0 0 (59,312) 0 (59,312)
Conversion of preferred stock to common stock (in shares)                             7,937 (7,937) 0        
Conversion of preferred stock to common stock                             $ 8 $ (79) $ 0 71 0 0 0
Exchange of shares for Series B Warrants (in shares)                             2,041 0 0        
Exchange of shares for Series B Warrants                             $ 2 $ 0 $ 0 2,468 0 0 2,470
Balance (in shares) at Dec. 31, 2020                             116,231 0 0        
Balance at Dec. 31, 2020                             $ 116 $ 0 $ 0 $ 781,397 $ (722,912) $ 2,968 $ 61,569